Register now for FREE unlimited access to reuters.com
Nov 24 (Reuters) – Johnson & Johnson (JNJ.N) said on Wednesday that Canada has given full approval to its single-shot COVID-19 vaccine for people aged 18 and older, making it the first full approval for the vaccine worldwide.
The vaccine had previously been approved by the country under an interim order. (https://refini.tv/30Zd5TR)
Canada, which reports an average of 2,563 infections each day and has administered at least 60,101,058 doses of COVID-19 vaccines to date, has given full approval to Moderna Inc. (MRNA.O) and Pfizer Incs (PFE.N) coronavirus vaccines in September.
The country this month approved the use of Pfizer’s COVID-19 vaccine for children ages 5 to 11 and a booster dose for people ages 18 and older. read more
J&J’s coronavirus vaccine is approved for emergency use in many countries, including the United States.
Reporting by Dania Nadeem in Bengaluru; Editing by Shounak Dasgupta
Our standards: The Thomson Reuters Trust Principles.